Coronavirus disease 2019: ethical and epidemiological issues with clinical trials

Authors

  • Tugolbai Tagaev Department of Public Health and Healthcare, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan https://orcid.org/0000-0002-3102-6524
  • Yethindra Vityala Department of Pathology, International Higher School of Medicine, International University of Kyrgyzstan, Bishkek, Kyrgyzstan https://orcid.org/0000-0003-1007-2422
  • Altynai Zhumabekova City Maternity Hospital No. 2, Bishkek, Kyrgyzstan
  • Yogesh Parihar International Higher School of Medicine, International University of Kyrgyzstan, Bishkek, Kyrgyzstan
  • Alenur Narasimharaj International Higher School of Medicine, International University of Kyrgyzstan, Bishkek, Kyrgyzstan

DOI:

https://doi.org/10.15584/ejcem.2021.2.14

Downloads

Download data is not yet available.

References

Wendler D, Rid A. In Defense of a Social Value Requirement for Clinical Research. Bioethics. 2017;31(2):77-86.

Annas GJ. Beyond Nazi War Crimes Experiments: The Voluntary Consent Requirement of the Nuremberg Code at 70. Am J Public Health. 2018;108(1):42-46.

World Health Organization. Guidance for managing ethical issues in infectious disease. [Online] Available at: https://www.who.int/tdr/news/2016/ethical-issues-in-inf-dis-outbreaks/en/ (Accessed December 11, 2020).

Zhang T, He Y, Xu W, Ma A, Yang Y, Xu KF. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Sci China Life Sci. 2020;63(5):774-776.

U. S. National Library of Medicine. ClinicalTrials.gov: COVID-19. [Online] Available at: https://clinicaltrials.gov/ct2/results?cond=COVID-19 (Accessed December 11, 2020).

INSERM. Covid-19: Démarrage de l'essai clinique Discovery. [Online] Available at: https://www.inserm.fr/actualites-et-evenements/actualites/covid-19-demarrage-essai-clinique-discovery (Accessed December 12, 2020).

Hashem H, Abufaraj M, Tbakhi A, Sultan I. Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic. Front Med (Lausanne). 2020;7:598038.

Rome BN, Avorn J. Drug Evaluation during the Covid-19 Pandemic. N Engl J Med. 2020;382(24):2282-2284.

Fowler RA, Webb SA, Rowan KM, et al. Early observational research and registries during the 2009-2010 influenza A pandemic. Crit Care Med. 2010;38(4):e120-e32.

Couderc B, Duguet A-N, Cambon-Thomsen A, Rial-Sebbag E. Clinical trial and treatment: what ethics in a health emergency?. Available at: https://exploreur.univ-toulouse.fr/essai-clinique-et-traitement-quelle-ethique-en-cas-durgence-sanitaire (Accessed December 12, 2020).

Han Z, Wang J, Zhang K, Tang Q. The ethics of COVID-19 clinical trials: New considerations in a controversial area. Integr Med Res. 2020;9(3):100425.

Hirsch F. Clinical trials: practices and regulations in France. The Conversation. [Online] Available at: https://theconversation.com/essais-cliniques-pratiques-et-reglementation-en-france-53331 (Accessed December 16, 2020).

Ferry-Danini J. Little introduction to the ethics of clinical trials. Medium.com. [Online] Available at: https://medium.com/@ferry.danini/petite-introduction-à-léthique-des-essaiscliniquesd1b6d9f0bbb2 (Accessed December 18, 2020).

Paternotte C. Against the method?. Medium.com. [Online] Available at: https://medium.com/@cedpatern/contre-la-méthode-cf4b173c0bc0 (Accessed December 22, 2020).

Hirsch E. Biomedical research: what ethical principles in times of a pandemic?. The Conversation. [Online] Available at: https://theconversation.com/recherche-biomedicale-quels-principes-ethiques-en-tempsdepandemie-134829 (Accessed December 22, 2020).

Hirsch F, Boissieu P. Clinical trials: we can reconcile ethics, quality and urgency even in times of health crisis. The Conversation. [Online] Available at: https://theconversation.com/essais-cliniques-on-peut-concilier-ethique-qualite-eturgence-memeen-temps-de-crise-sanitaire-135461 (Accessed December 22, 2020).

European Patient Academy (EUPATI). News clinical trial approaches: adaptive methodologies. [Online] Available at: https://www.eupati.eu/fr/developpement-et-essais-cliniques/nouvelles-approches-desessaiscliniques-methodologies-adaptatives/ (Accessed December 22, 2020).

Downloads

Published

2021-06-30

How to Cite

Tagaev, T., Vityala, Y., Zhumabekova, A., Parihar, Y., & Narasimharaj, A. (2021). Coronavirus disease 2019: ethical and epidemiological issues with clinical trials. European Journal of Clinical and Experimental Medicine, 19(2), 197–199. https://doi.org/10.15584/ejcem.2021.2.14

Issue

Vol. 19 No. 2 (2021)

Section

LETTERS TO THE EDITOR

License

Copyright (c) 2021 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.

Most read articles by the same author(s)